Stock 300246 GUANGDONG BIOLIGHT MEDITECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Guangdong Biolight Meditech Co., Ltd.

Equities

300246

CNE1000015Q4

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-25 EDT 		5-day change 1st Jan Change
6.55 CNY +0.92% Intraday chart for Guangdong Biolight Meditech Co., Ltd. +5.48% -36.41%
04-24 Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,606 2,261 3,795 3,192 2,869 2,725
Enterprise Value (EV) 1 1,528 2,260 3,580 3,212 2,517 2,811
P/E ratio 25 x 35.2 x 11 x 50 x 128 x -41.7 x
Yield 0.91% 1.29% 1.54% 0.92% 1.23% -
Capitalization / Revenue 1.97 x 2.74 x 2.72 x 2.93 x 2.42 x 2.28 x
EV / Revenue 1.88 x 2.74 x 2.56 x 2.94 x 2.13 x 2.35 x
EV / EBITDA 15.8 x 21 x 8.09 x 29.6 x 68.1 x 22.6 x
EV / FCF -28.2 x 90.5 x 14.5 x -28.8 x -20.5 x -7.22 x
FCF Yield -3.54% 1.11% 6.9% -3.47% -4.89% -13.8%
Price to Book 2.86 x 4.13 x 4.13 x 3.57 x 2.03 x -
Nbr of stocks (in thousands) 219,132 219,132 219,132 219,137 263,683 264,574
Reference price 2 7.327 10.32 17.32 14.57 10.88 10.30
Announcement Date 19-04-25 20-04-23 21-05-12 22-04-25 23-04-18 24-04-24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 813.4 826 1,396 1,091 1,184 1,194
EBITDA 1 96.9 107.7 442.5 108.4 36.95 124.5
EBIT 1 83.3 94.27 425.3 72.6 -6.64 74.2
Operating Margin 10.24% 11.41% 30.46% 6.65% -0.56% 6.21%
Earnings before Tax (EBT) 1 91.49 89.55 417.2 77.88 22.14 -46.16
Net income 1 64.19 64.71 346.1 63.79 22 -65.19
Net margin 7.89% 7.83% 24.8% 5.85% 1.86% -5.46%
EPS 2 0.2929 0.2933 1.576 0.2911 0.0849 -0.2470
Free Cash Flow 1 -54.15 24.98 247 -111.5 -123 -389.1
FCF margin -6.66% 3.02% 17.69% -10.22% -10.39% -32.59%
FCF Conversion (EBITDA) - 23.2% 55.81% - - -
FCF Conversion (Net income) - 38.6% 71.35% - - -
Dividend per Share 2 0.0667 0.1333 0.2667 0.1333 0.1333 -
Announcement Date 19-04-25 20-04-23 21-05-12 22-04-25 23-04-18 24-04-24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 20 - 86.3
Net Cash position 1 77.8 1.69 215 - 352 -
Leverage (Debt/EBITDA) - - - 0.1842 x - 0.6927 x
Free Cash Flow 1 -54.2 25 247 -112 -123 -389
ROE (net income / shareholders' equity) 13.3% 12.1% 43.5% 6.64% 1.96% -4.22%
ROA (Net income/ Total Assets) 6.06% 6.27% 20.7% 2.73% -0.2% 1.86%
Assets 1 1,059 1,032 1,673 2,339 -11,027 -3,496
Book Value Per Share 2 2.570 2.500 4.190 4.080 5.370 -
Cash Flow per Share 2 0.7800 0.7100 1.970 1.540 1.660 -
Capex 1 99.8 47 68.4 163 212 220
Capex / Sales 12.27% 5.69% 4.9% 14.98% 17.89% 18.45%
Announcement Date 19-04-25 20-04-23 21-05-12 22-04-25 23-04-18 24-04-24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. Stock Guangdong Biolight Meditech Co., Ltd.
-36.41% 239M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.11% 187B
MEDTRONIC PLC Stock Medtronic plc
-1.92% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.05% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
-0.57% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+16.30% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.63% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.49% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 300246 Stock
  4. Financials Guangdong Biolight Meditech Co., Ltd.